期刊
SCIENTIFIC REPORTS
卷 9, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-019-49264-0
关键词
-
资金
- Medical Research Council (MRC)
- Wellcome Trust
- BBSRC [BB/R000344/1] Funding Source: UKRI
beta-Lactamases are a major threat to the clinical use of carbapenems, which are often antibiotics of last resort. Despite this, the reaction outcomes and mechanisms by which beta-lactamases degrade carbapenems are still not fully understood. The carbapenem bicyclic core consists of a beta-lactam ring fused to a pyrroline ring. Following beta-lactamase-mediated opening of the beta-lactam, the pyrroline may interconvert between an enamine (2-pyrroline) form and two epimeric imine (1-pyrroline) forms; previous crystallographic and spectroscopic studies have reported all three of these forms in the contexts of hydrolysis by different beta-lactamases. As we show by NMR spectroscopy, the serine beta-lactamases (KPC-2, SFC-1, CMY-10, OXA-23, and OXA-48) and metallo-beta-lactamases (NDM-1, VIM-1, BcII, CphA, and L1) tested all degrade carbapenems to preferentially give the Delta(2) (enamine) and/or (R)-Delta(1) (imine) products. Rapid non-enzymatic tautomerisation of the Delta(2) product to the (R)-Delta(1) product prevents assignment of the nascent enzymatic product by NMR. The observed stereoselectivity implies that carbapenemases control the form of their pyrroline ring intermediate(s)/product(s), thereby preventing pyrroline tautomerisation from inhibiting catalysis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据